Morgan Stanley Maintains Equal-Weight on Oscar Health, Raises Price Target to $7.5
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Equal-Weight rating on Oscar Health (NYSE:OSCR) and raises the price target from $5 to $7.5.
August 30, 2023 | 2:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley maintains an Equal-Weight rating on Oscar Health and raises the price target from $5 to $7.5, which could potentially attract investors.
The raised price target by Morgan Stanley indicates a positive outlook for Oscar Health. This could potentially attract investors, leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100